< back to case studies
Assessment of the synergistic anti-tumour potency of novel drug formulations by means of 3D X-ray Histology
Orestis L. Katsamenis1*, Christina Karavasili2, Dimitrios G. Fatouros2
1 μ-VIS X-Ray Imaging Centre, Faculty of Engineering and the Environment, University of Southampton, SO17 1BJ Southampton, UK;
2 Laboratory of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Hellas;
Combination chemotherapy is currently arising as means of overcoming multidrug resistance and enhancing therapeutic response, while reducing administered drug dose and side effects. The term refers to the delivery method that utilises the synergistic (or additive) effect of multiple anticancer agents in a co-delivery formulation. Doxorubicin (DOX) is an anticancer agent used to treat a wide range of cancers and despite its high toxicity it remains in use because of its efficacy in the treatment of several types of tumours [1]. Curcumin (CUR) is a polyphenol originating from the rhizomes of turmeric and has been broadly evaluated for its anticancer potential [2]. The utilisation of nutritional constituents in therapeutics, often referred to as Nutraceuticals, encompass multitargeting efficacy and lower toxicity compared to the conventional synthetic moieties.
In this study we have synthesised and assessed the therapeutic potency of the ac-(RADA)4-CONH2 self-assembling peptide hydrogel for the co-delivery of DOX and CUR against head and neck cancer cells in HSC-3 cell-xenografted severe combined immunodeficient mice. 3D X-ray histology (XRH)* was employed to provide high-resolution 3D (volumetric) anatomic information of tumour response after treatment by analysing the phenotype of the excised tumours (figure). XRH imaging of the excised tumours allowed us to quantitively analyse the volumetric characteristics of anatomical features, such as tumour volume, its necrotic core and calcifications.
Investigation of the ratio between the total tumour volume and the necrotic tissue volume within them highlighted the efficacy of the DOX+CUR peptide hydrogel to enhance tumour necrosis and suppress cell proliferation. Our study demonstrates that 3D X-ray histology is a powerful tool for providing high-resolution anatomic information of tumour biopsies after intratumoral administration of chemotherapeutic formulations.
* 3D X-ray histology (XRH) is a µCT-based workflow for imaging unstained paraffinized tissue specimens developed in the University of Southampton, tailored to fit seamlessly into current histology workflows [3].
[1] P. K. Singal and N. Iliskovic, “Doxorubicin-induced cardiomyopathy“, New England Journal of Medicine, vol. 339, no. 13, pp. 900-905, 1998
[2] R. Wilken, M. S. Veena, M. B. Wang, and E. S. Srivatsan, “Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma“, Molecular cancer, vol. 10, no. 1, p. 12, 2011
[3] O. L. Katsamenis et al., “X-ray micro-computed tomography for non-destructive 3D X-ray histology“, The American journal of pathology, 2019
Other case studies:
Correlative XRH - EM placental imaging
XRH was utilised to investigate the structural diversity of placental villi in humans and equids (horses and related species), which despite their common evolutionary origins exhibit markedly different placental structures that may influence nutrient transfer efficiency. By combining XRH with electron microscopy (EM), the study aimed to elucidate these structural differences and their functional implications.
Identification of regional diversity in blood vessel structure within murine cortical bone
Bone is a dynamic tissue which is actively remodelled throughout life. It relies upon a constant blood supply for the provision of oxygen and nutrients. The cortex or outer shell of most of our bones is perforated by an interconnected network of vascular canals and bone cell survival depends on the proximity to this vascular network. Recent evidence has emerged that low bone mass, deterioration of bone tissue and disruption of bone microarchitecture in osteoporosis may be driven by reduced angiogenic signals and vascular supply. A thorough investigation of this hypothesis is currently limited by challenges related to imaging of the bone vascular network, which is deeply enclosed in mineralised bone tissue.
Correlative Imaging and Microfluidic Modelling of Human Pulmonary Lymphatics
Lung lymphatics maintain fluid homoeostasis by providing a drainage system that returns fluid, cells and metabolites to the circulatory system. The 3D structure of the human pulmonary lymphatic network is essential to the lung function, but it is poorly characterised. Image-based 3D mathematical modelling of pulmonary lymphatic microfluidics has been limited by the lack of the accurate and representative image geometries. This is due to the microstructural similarity of the lymphatics to the blood vessel network, the lack of lymphatic-specific biomarkers, and the technical limitations associated with image resolution in 3D techniques and sectioning artefacts present in 2D techniques.
Mapping 3D Networks in Human Lung tissue using Micro-Computed Tomography
Micro-computed tomography (µCT) is a non-destructive imaging technique that can reveal the 3D lung microstructure. 3D networks in µCT images are generally identified and segmented by manually tracing their outline, which is very time consuming and requires specialist knowledge of the tissue. We devised a new method to segment 3D networks semi-automatically and specific cell types by correlating µCT imaging with immunofluorescence microscopy.
Assessment of the synergistic anti-tumour potency of novel drug formulations by means of 3D X-ray Histology
In this study we have synthesised and assessed the therapeutic potency of the ac-(RADA)4-CONH2 self-assembling peptide hydrogel for the co-delivery of DOX and CUR against head and neck cancer cells in HSC-3 cell-xenografted severe combined immunodeficient mice. 3D X-ray histology (XRH)* was employed to provide high-resolution 3D (volumetric) anatomic information of tumour response after treatment by analysing the phenotype of the excised tumours (figure). XRH imaging of the excised tumours allowed us to quantitively analyse the volumetric characteristics of anatomical features, such as tumour volume, its necrotic core and calcifications.